Adularia

About

Recolony AG is a Swiss startup focused on developing microbiome-based therapies to combat colorectal cancer. By leveraging the power of beneficial bacteria, Recolony aims to create innovative treatments that can improve patient outcomes and provide a novel approach to cancer therapy. The company is at the intersection of microbiology and oncology, seeking to harness the potential of the human microbiome in fighting cancer.